Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison R Greenplate

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Cell Reports|October 16, 2022
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two dosesAlexandra Tauzin, Shang Yu Gong, Debashree Chatterjee, et al.
Critical Care Explorations|December 8, 2022
Validating a Proteomic Signature of Severe COVID-19Christopher V Cosgriff, Todd A Miano, Divij Mathew, et al.
Science Immunology|January 16, 2021
Inhibitory signaling sustains a distinct early memory CD8<sup>+</sup> T cell precursor that is resistant to DNA damageJonathan B Johnnidis, Yuki Muroyama, Shin Foong Ngiow, et al.
Cell|February 24, 2022
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individualsKatlyn Lederer, Emily Bettini, Kalpana Parvathaneni, et al.
Nature Medicine|September 15, 2021
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapySokratis A Apostolidis, Mihir Kakara, Mark M Painter, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2020
SARS-CoV-2 Seroprevalence Among Parturient WomenDustin D Flannery, Sigrid Gouma, Miren B Dhudasia, et al.
Science Immunology|July 31, 2020
SARS-CoV-2 seroprevalence among parturient women in PhiladelphiaDustin D Flannery, Sigrid Gouma, Miren B Dhudasia, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Immunologic perturbations in severe COVID-19/SARS-CoV-2 infectionLeticia Kuri-Cervantes, M Betina Pampena, Wenzhao Meng, et al.
Medrxiv : the Preprint Server for Health Sciences|July 17, 2025
Large-scale evaluation of proteomic and polygenic risk scores reveals complementary contributions to incident disease predictionJakob Woerner, Thomas M Westbrook, Jaehyun Joo, et al.
Immunity|August 28, 2021
Rapid induction of antigen-specific CD4<sup>+</sup> T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccinationMark M Painter, Divij Mathew, Rishi R Goel, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Cell Reports|October 16, 2022
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two dosesAlexandra Tauzin, Shang Yu Gong, Debashree Chatterjee, et al.
Critical Care Explorations|December 8, 2022
Validating a Proteomic Signature of Severe COVID-19Christopher V Cosgriff, Todd A Miano, Divij Mathew, et al.
Science Immunology|January 16, 2021
Inhibitory signaling sustains a distinct early memory CD8<sup>+</sup> T cell precursor that is resistant to DNA damageJonathan B Johnnidis, Yuki Muroyama, Shin Foong Ngiow, et al.
Cell|February 24, 2022
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individualsKatlyn Lederer, Emily Bettini, Kalpana Parvathaneni, et al.
Nature Medicine|September 15, 2021
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapySokratis A Apostolidis, Mihir Kakara, Mark M Painter, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2020
SARS-CoV-2 Seroprevalence Among Parturient WomenDustin D Flannery, Sigrid Gouma, Miren B Dhudasia, et al.
Science Immunology|July 31, 2020
SARS-CoV-2 seroprevalence among parturient women in PhiladelphiaDustin D Flannery, Sigrid Gouma, Miren B Dhudasia, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Immunologic perturbations in severe COVID-19/SARS-CoV-2 infectionLeticia Kuri-Cervantes, M Betina Pampena, Wenzhao Meng, et al.
Medrxiv : the Preprint Server for Health Sciences|July 17, 2025
Large-scale evaluation of proteomic and polygenic risk scores reveals complementary contributions to incident disease predictionJakob Woerner, Thomas M Westbrook, Jaehyun Joo, et al.
Immunity|August 28, 2021
Rapid induction of antigen-specific CD4<sup>+</sup> T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccinationMark M Painter, Divij Mathew, Rishi R Goel, et al.
Pageof 8